Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

2 Therapeutics

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
ACI-7104.056	ACI-7104, Affitope PD01A, PD03A	Parkinson's Disease (Phase 2), Multiple System Atrophy (Phase 1)	AC Immune SA, AFFiRiS AG	alpha-synuclein	Immunotherapy (active)
UB-312		Parkinson's Disease (Phase 2)	United Neuroscience, Vaxxinity	alpha-synuclein	Immunotherapy (active)